Emphysema
Adult: As maintenance in patients w/ severe alpha1-proteinase inhibitor deficiency: 60 mg/kg once wkly via infusion approx 0.08 mL/kg/min. Adjust infusion rate based upon patient tolerability.
Chỉ định và Liều dùng
Intravenous
Emphysema Adult: As maintenance in patients w/ severe alpha1-proteinase inhibitor deficiency: 60 mg/kg once wkly via infusion approx 0.08 mL/kg/min. Adjust infusion rate based upon patient tolerability.
|
Chống chỉ định
Hypersensitivity. IgA deficient patients w/ antibodies against IgA.
|
Thận trọng
Patient at risk for fluid overload. Pregnancy and lactation.
|
Tác dụng không mong muốn
Significant: Risk of infection transmission (e.g. viruses such as Creutzfeldt-Jakob disease). Hypersensitivity reactions (e.g. anaphylaxis).
Nervous: Dizziness, somnolence, flu-like symptoms, headache, paraesthesia, asthenia. CV: Flushing, chest pain or discomfort hypotension, tachycardia, vasodilatation, peripheral oedema. GI: Nausea, oral candidiasis, sore throat. Resp: Dyspnoea, upper resp tract infection, cough, sinusitis. Hepatic: Increased hepatic enzyme. Genitourinary: UTI. Haematologic: Haemorrhage. Musculoskeletal: Musculoskeletal pain, back pain, weakness. Dermatologic: Pruritus, urticaria. Others: Infusion-site reactions, fever, chills. |
Thông tin tư vấn bệnh nhân
This drug may cause dizziness, if affected, do not drive or operate machinery.
|
Chỉ số theo dõi
Closely monitor clinical state (e.g. vital signs), infusion rate, and signs of infusion-related reactions e.g. anaphylactic reactions. Monitor α1-PI serum levels and lung function.
|
Tác dụng
Description:
Mechanism of Action: Human alpha-1 proteinase inhibitor is the primary anti-protease in the lower resp tract inhibiting serine proteases e.g. neutrophil elastase, an enzyme that aids in the proteolytic destruction of the connective tissue framework of the lung parenchyma. It protects lung tissue proteolysis in individuals deficient in alpha1-proteinase inhibitor. Pharmacokinetics: Absorption: Time to peak plasma concentration: Approx 1 hr. Distribution: Volume of distribution: Approx 3.5 L. Excretion: Elimination half-life: 5-6 days (metabolic). |
Bảo quản
Store below 25°C.
|
Phân loại MIMS
|
Tài liệu tham khảo
Anon. Alpha1-proteinase Inhibitor. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 07/08/2017. Anon. Glassia Injection Solution (Baxalta US Inc.). Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 07/08/2017. Buckingham R (ed). Alpha1-proteinase Inhibitor. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 07/08/2017. McEvoy GK, Snow EK, Miller J et al (eds). α1-Proteinase Inhibitor (Human). AHFS Drug Information (AHFS DI) [online]. American Society of Health-System Pharmacists (ASHP). https://www.medicinescomplete.com. Accessed 07/08/2017.
|